Pandora Jewelry and Woori Bank Sign 74K SF of Long-Term Office Leases at 1540 Broadway
GFP Real Estate and BDT & MSD Partners have secured more than 74,000 square feet of new long-term office leases
Steve Griffin
March 6, 2026
GFP Real Estate and BDT & MSD Partners have secured more than 74,000 square feet of new long-term office leases
Marcus & Millichap has completed the $9.75 million sale of a development site at 42-81 Hunter St. in the Court
West Capital Lending has acquired a Class A office building in Irvine’s Irvine Concourse submarket for use as a new
Marx Realty has started work on a new phase of retail development at Cross County Center in Yonkers, NY, advancing
Related California and Bay Area Rapid Transit (BART) have started construction on the first phase of a transit-oriented development at
Clear Height Properties and joint venture partner Harbert Management Corporation have completed the disposition of Triangle Corporate Center, a multi-tenant
The sale of a six-unit multifamily property in Boston’s Brighton neighborhood for $4,595,000 was successfully arranged by Marcus & Millichap.
Cushman & Wakefield has successfully assisted Lincoln Equities Group and PCCP, LLC in obtaining $126,290,000 in refinancing for their newly-constructed
Cushman & Wakefield has successfully assisted Lincoln Equities Group and PCCP, LLC in obtaining a $126,290,000 refinancing for their newly-built
JEMB Realty has recently signed a long-term lease with Rubenstein Law, a Miami-based personal injury firm. The lease is for
Vaxcyte, Inc., a clinical-stage biopharmaceutical company, has signed a 10-year lease with Alexandria Real Estate Equities, Inc. for 258,581 square
Cushman & Wakefield recently advised RPG, a San Diego-based company, in the forward sale of an 88,552-square-foot industrial building located
Coastal Ridge, a company specializing in real estate investment, development and property management for rental properties, has welcomed Peter Kelly
Trammell Crow Company (TCC) has recently secured a lease agreement with COUR Pharmaceuticals, a leading biotechnology company specializing in autoimmune